New Expert Group To Drive European Pharmacopoeial Standards For mRNA Vaccines

With growing interest in expanding the use of mRNA vaccines beyond COVID-19, the European Pharmacopoeia Commission has announced a new working party whose first task will be to develop a consolidated strategy on future standards for these vaccines and their components.